Curiouser and Curiouser
You don't say.
Top FDA vaccine officials to leave agency as decision on COVID-19 boosters looms
In a memo to agency staff, acting FDA head Janet Woodcock expressed confidence in the team that will remain in place under the leadership of CBER director Peter Marks.
www.biopharmadive.com
'Marion Gruber and Phil Krause, two of the Food and Drug Administration's top vaccine reviewers, are leaving the agency, the regulator confirmed on Tuesday.'
...
'The White House announced plans to begin administering boosters the week of Sept. 20, a debated decision that got ahead of the completion of the FDA's own review. The Biden administration drew criticism for the public announcement, which puts considerable pressure on the regulator to clear boosters in time for the planned rollout despite lack of definitive proof they are needed broadly for healthy adults.'
...
'Their sudden and near concurrent departures could raise questions about the impact political pressure, now spanning two administrations, is having on the agency.'
You don't say.